These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38463677)

  • 1. Prognostic Implication of Platelet Reactivity According to Procedural Complexity After PCI: Subanalysis of PTRG-DES Consortium.
    Jin X; Jeong YH; Lee KM; Yun SC; Kim BK; Joo HJ; Chang K; Park YW; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Lim DS; Shin ES; Kim MH;
    JACC Asia; 2024 Mar; 4(3):185-198. PubMed ID: 38463677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium.
    Jeon KH; Jeong YH; Chae IH; Kim BK; Joo HJ; Chang K; Park Y; Song YB; Ahn SG; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Lim DS; Shin ES; Suh JW;
    Cardiovasc Diabetol; 2023 Sep; 22(1):245. PubMed ID: 37679760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implication of Platelet Reactivity According to Left Ventricular Systolic Dysfunction Status in Patients Treated With Drug-Eluting Stent Implantation: Analysis of the PTRG-DES Consortium.
    Han D; Kim SH; Shin DG; Kang MK; Choi S; Lee N; Kim BK; Joo HJ; Chang K; Park Y; Song YB; Ahn SG; Suh JW; Lee SY; Her AY; Jeong YH; Kim HS; Kim MH; Lim DS; Shin ES; Cho JR;
    J Korean Med Sci; 2024 Jan; 39(3):e27. PubMed ID: 38258362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents in East Asian Patients: Results From the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) Consortium.
    Kim SJ; Her AY; Jeong YH; Kim BK; Joo HJ; Park Y; Chang K; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Kim HS; Kim MH; Lim DS; Shin ES;
    J Am Heart Assoc; 2023 May; 12(9):e027804. PubMed ID: 37119080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium.
    Lee SJ; Cha JJ; Jeong YH; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; Joo HJ; Chang K; Park Y; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Shin ES; Lim DS; Kim BK;
    JACC Cardiovasc Interv; 2022 Nov; 15(22):2253-2265. PubMed ID: 36423968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention.
    Kim SE; Jeon HS; Go TH; Lee JH; Lee JW; Youn YJ; Kim BK; Joo HJ; Lim DS; Chang K; Park Y; Song YB; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Shin ES; Gorog DA; Tantry US; Gurbel PA; Jeong YH; Ahn SG;
    Clin Pharmacol Ther; 2023 Nov; 114(5):1104-1115. PubMed ID: 37597219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
    Rubin GA; Kirtane AJ; Chen S; Redfors B; Weisz G; Baber U; Zhang Y; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Ali ZA; Ben-Yehuda O; Stone GW
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):793-801. PubMed ID: 31721430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Coronary Intervention of Saphenous Vein Graft.
    Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
    Redfors B; Généreux P; Witzenbichler B; Maehara A; Weisz G; McAndrew T; Mehran R; Kirtane AJ; Stone GW
    Am Heart J; 2018 Mar; 197():142-149. PubMed ID: 29447774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium.
    Her AY; Jeong YH; Kim BK; Joo HJ; Chang K; Park Y; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Kim HS; Kim MH; Lim DS; Shin ES;
    Yonsei Med J; 2022 May; 63(5):413-421. PubMed ID: 35512743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation.
    Généreux P; Giustino G; Redfors B; Palmerini T; Witzenbichler B; Weisz G; Stuckey TD; Maehara A; Mehran R; Kirtane AJ; Stone GW
    Int J Cardiol; 2018 Oct; 268():61-67. PubMed ID: 30041804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study.
    Gao XF; Lu S; Ge Z; Zuo GF; Wang ZM; Wang F; Kong XQ; Chai DY; Chen SL; Zhang JJ
    BMC Cardiovasc Disord; 2018 May; 18(1):103. PubMed ID: 29793432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.
    Finn MT; Redfors B; Karmpaliotis D; Kirtane AJ; Green P; McAndrew T; Liu M; Cloney MB; Witzenbichler B; Weisz G; Stuckey TD; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stone GW
    Am Heart J; 2019 May; 211():68-76. PubMed ID: 30897527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES.
    Chau KH; Kirtane AJ; Easterwood RM; Redfors B; Zhang Z; Witzenbichler B; Weisz G; Stuckey TD; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2021 Feb; 14(4):417-427. PubMed ID: 33516690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention.
    Lee SH; Jeong YH; Hong D; Choi KH; Lee JM; Park TK; Yang JH; Hahn JY; Choi SH; Gwon HC; Jeong MH; Kim BK; Joo HJ; Chang K; Park Y; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Lim DS; Shin ES; Song YB;
    JACC Cardiovasc Interv; 2023 Apr; 16(7):829-843. PubMed ID: 37045504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes After Percutaneous Coronary Intervention in East Asian Patients　- 30-Month Results of the PENDULUM Registry.
    Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Akasaka T; Shinke T; Ueno T; Hirayama A; Uemura S; Harada A; Kuroda T; Takita A; Iijima R; Murakami Y; Saito S; Nakamura M
    Circ J; 2022 Aug; 86(9):1339-1349. PubMed ID: 35569930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.